Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer

被引:40
|
作者
Yang, Fan [1 ]
Liu, Ye-huan [1 ]
Dong, Si-yang [1 ]
Yao, Zhi-han [1 ]
Lv, Lin [1 ]
Ma, Rui-min [1 ]
Dai, Xuan-xuan [1 ]
Wang, Jiao [2 ]
Zhang, Xiao-hua [1 ]
Wang, Ou-chen [1 ]
机构
[1] Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Triple-negative breast cancer; Long non-coding RNA; RMST; Expression profile; LONG NONCODING RNAS; TRANSCRIPTOME ANALYSIS; IDENTIFICATION; EXPRESSION; SUBTYPES;
D O I
10.1016/j.gene.2016.07.002
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with unfavorable outcome. It is urgent to explore novel biomarkers and potential therapeutic targets in this malignancy. Increasing knowledge of long noncoding RNAs (lncRNAs) significantly deepens our understanding of cancer biology. Here, we sequenced eight paired TNBC tumor tissues and non-cancerous tissues, and validated significantly differentially expressed IncRNAs. Gene ontology (GO) and pathway analysis were used to investigate the function of differentially expressed mRNAs. Further, potential core lncRNAs in TNBC were identified by co-expression networks. Kaplan-Meier analysis also indicated that breast cancer patients with lower expression level of rhabdomyosarcoma 2 associated transcript (RMST), one of the potential core IncRNAs, had worse overall survival. To the best of our knowledge, it was the first report that RMST was involved in breast cancer. Our research provided a rich resource to the research community for further investigating lncRNAs functions and identifying lncRNAs with diagnostic and therapeutic potentials in TNBC. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 50 条
  • [21] Triple-negative breast cancer
    Chacon, Reinaldo D.
    Costanzo, Maria V.
    BREAST CANCER RESEARCH, 2010, 12
  • [22] Triple-negative breast cancer
    Stockmans, Gert
    Deraedt, Karen
    Wildiers, Hans
    Moerman, Philippe
    Paridaens, Robert
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
  • [23] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1938 - 1948
  • [24] Triple-negative breast cancer
    Bartsch R.
    Ziebermayr R.
    Zielinski C.C.
    Steger G.G.
    Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 174 - 181
  • [25] Triple-Negative Breast Cancer
    Liedtke, Cornelia
    Schmutzler, Rita
    Schneeweiss, Andreas
    Loibl, Sybille
    Thill, Marc
    Heitz, Florian
    BREAST CARE, 2010, 5 (05) : 359 - 363
  • [26] Triple-negative breast cancer
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (08) : 22 - 23
  • [27] Triple-negative breast cancer
    Reinaldo D Chacón
    María V Costanzo
    Breast Cancer Research, 12
  • [28] Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple-negative breast cancer
    Guiu, S.
    Charon-Barra, C.
    Mollevi, C.
    Boissiere, F.
    Crapez, E.
    Chartron, E.
    Lamy, P-J
    Gutowski, M.
    Bourgier, C.
    Romieu, G.
    Simony-Lafontainc, J.
    Jacot, W.
    CANCER RESEARCH, 2017, 77
  • [29] Evaluation of lncRNAs as Potential Biomarkers for Diagnosis of Metastatic Triple-Negative Breast Cancer through Bioinformatics and Machine Learning
    Soleimani, Shiva
    Pouresmaeili, Farkhondeh
    Far, Iman Salahshoori
    IRANIAN JOURNAL OF BIOTECHNOLOGY, 2024, 22 (03)
  • [30] Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis
    Hsu, Huan-Ming
    Chu, Chi-Ming
    Chang, Yu-Jia
    Ye, Jyh-Cherng
    Chen, Chien-Ting
    Jian, Chen-En
    Lee, Chia-Yi
    Chiang, Yueh-Tao
    Chang, Chi-Wen
    Chang, Yu-Tien
    SCIENTIFIC REPORTS, 2019, 9 (1)